Resultats de la cerca - Hans‐Henrik Parving

Refinar resultats
  1. 1
    Diabetic nephropathy: Prevention and treatment

    Diabetic nephropathy: Prevention and treatment per Hans‐Henrik Parving

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Transcapillary Escape Rate of Albumin and Plasma Volume in Essential Hypertension

    Transcapillary Escape Rate of Albumin and Plasma Volume in Essential Hypertension per Hans‐Henrik Parving, Finn Gyntelberg

    Publicat 1973
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Diabetic Nephropathy

    Diabetic Nephropathy per Lionel H. Opie, Hans‐Henrik Parving

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  4. 4
    Genetics of diabetic nephropathy.

    Genetics of diabetic nephropathy. per Hans‐Henrik Parving, Lise Tarnow, Peter Rossing

    Publicat 1996
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients

    Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients per Peter Rossing, Philip Hougaard, Hans‐Henrik Parving

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study

    Progression of microalbuminuria in type 1 diabetes: Ten-year prospective observational study per Peter Rossing, Philip Hougaard, Hans‐Henrik Parving

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria

    Kidney Function During and After Withdrawal of Long-Term Irbesartan Treatment in Patients With Type 2 Diabetes and Microalbuminuria per Steen Andersen, Jens Brøchner‐Mortensen, Hans‐Henrik Parving

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients

    Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients per Per K. Christensen, Henrik Post Hansen, Hans‐Henrik Parving

    Publicat 1997
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Microalbuminuria as an Early Marker for Cardiovascular Disease

    Microalbuminuria as an Early Marker for Cardiovascular Disease per Dick de Zeeuw, Hans‐Henrik Parving, Robert H. Henning

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

    Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review per Frederik Persson, Morten Lindhardt, Peter Rossing, Hans‐Henrik Parving

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy

    Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy per Peter Hovind, Lise Tarnow, Per B. Oestergaard, Hans Henrik Parving

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy

    Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy per Kasper Rossing, Peter Karl Jacobsen, Lotte Pietraszek, Hans‐Henrik Parving

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

    Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes per Peter Gæde, Henrik Lund‐Andersen, Hans‐Henrik Parving, Oluf Pedersen

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

    Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes per Hans‐Henrik Parving, Hiddo J. Lambers-Heerspink, Dick de Zeeuw

    Publicat 2016
    Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  15. 15
    Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

    Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria per Steen Andersen, Harald Mischak, Petra Zürbig, Hans‐Henrik Parving, Peter Rossing

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy

    Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy per Peter Hovind, Lise Tarnow, Peter Rossing, Bendix Carstensen, Hans‐Henrik Parving

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study

    Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study per M.-A. Gall, Philip Hougaard, K. Borch‐Johnsen, Hans‐Henrik Parving

    Publicat 1997
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Progression of diabetic nephropathy

    Progression of diabetic nephropathy per Peter Hovind, Peter Rossing, Lise Tarnow, U. Smidt, Hans‐Henrik Parving

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients

    Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients per Hans-Henrik Parving, E. Hommel, Berit R. Jensen, Henrik Post Hansen

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively11See Editorial by Steffes, p. 378

    Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively11See Editorial by Steffes, p. 378 per Peter Hovind, Peter Rossing, Lise Tarnow, U. Smidt, Hans‐Henrik Parving

    Publicat 2001
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: